# TRILOGIC PHARMA LLC: Form D filings

TRILOGIC PHARMA LLC, a pharmaceuticals company in Montgomery, AL, filed 6 Form D notices with the SEC between 2009 and 2012. The latest, on August 1, 2012, reports $222,866 sold of a $323,750 offering to 11 investors.

Find out what TRILOGIC PHARMA LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20TRILOGIC%20PHARMA%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=TRILOGIC%20PHARMA%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Ftrilogic-pharma-llc-1427303)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20TRILOGIC%20PHARMA%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=TRILOGIC%20PHARMA%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Ftrilogic-pharma-llc-1427303)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Alabama](https://specstream.ai/data/form-d/state/alabama): 291 rows, by operating companies, filed since November 1, 2024, $14.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/alabama
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 5331 PERIMETER PARKWAY COURT, Montgomery, AL, 36116
- Phone: (334) 315-8981
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1427303

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 1, 2012 | New notice | $323,750 | $222,866 | $100,884 | 11 | Jun 12, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1427303/000142730312000002/0001427303-12-000002-index.htm) |
| Aug 15, 2011 | New notice | $450,000 | $415,000 | $35,000 | 15 | Feb 22, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1427303/000142730311000002/0001427303-11-000002-index.htm) |
| Apr 2, 2010 | Amendment | $1,000,000 | $735,000 | $265,000 | 17 | Dec 16, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1427303/000142730310000003/0001427303-10-000003-index.htm) |
| Jan 8, 2010 | Amendment | $1,000,000 | $425,000 | $575,000 | 17 | Dec 16, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1427303/000142730310000002/0001427303-10-000002-index.htm) |
| Jan 8, 2010 | New notice | $1,000,000 | $425,000 | $575,000 | 17 | Jan 16, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1427303/000142730310000001/0001427303-10-000001-index.htm) |
| May 20, 2009 | New notice | $1,600,000 | $1,600,000 | $0 | 51 | Sep 6, 2007 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1427303/000142730309000003/0001427303-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| HERMANT H. ALUR | Executive Officer, Director |  |
| WILLIAM VAN HOOSER | Director |  |
| WILLIAM C. MAICHLE | Director |  |
| ERNEST C. HORNSBY | Director |  |
| JAMES A. H. HARWICK | Executive Officer, Director |  |
| WESLEY R. HEATON | Executive Officer, Director |  |
| RANDY B. STANLEY | Director |  |
| ALEXANDER H. C. HARWICK | Director |  |
| DANIEL P. WILBANKS | Director |  |

[Every Form D from the week of Jul 30, 2012](https://specstream.ai/data/form-d/week/2012-07-30) · [All recent filings in Alabama](https://specstream.ai/data/form-d/state/alabama) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what TRILOGIC PHARMA LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).